Skip to content
ppharmaranks
Menu

Ergotamine Derivative drugs compared

Compare all 5 Ergotamine Derivative drugs side by side, used for conditions such as cluster headache, postpartum hemorrhage, hypotension, orthostatic. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.

Full ranking · 5 drugs

  1. 1

    brekiya (autoinjector)

    Dihydroergotamine Mesylate

    70/100
  2. 2

    atzumi

    Dihydroergotamine Mesylate

    New
  3. 3

    dihydroergotamine mesylate

    Dihydroergotamine Mesylate

    New
  4. 4

    migranal

    Dihydroergotamine Mesylate

    New
  5. 5

    trudhesa

    Dihydroergotamine Mesylate

    New

Frequently asked questions

What is the Ergotamine Derivative drug class?

Ergotamine Derivative is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 5 Ergotamine Derivative products, each independently rated.

Are all Ergotamine Derivative drugs the same?

No. Ergotamine Derivative drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.

What conditions do Ergotamine Derivative drugs treat?

Per NIH RxClass drug-classification data, Ergotamine Derivative drugs are used for conditions including cluster headache, postpartum hemorrhage, hypotension, orthostatic, migraine disorders, xerostomia.

Sources: the Ergotamine Derivative class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.